Cargando…
The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial
BACKGROUND: Interleukin-1 (IL-1) is a key mediator of ischaemic brain injury induced by stroke and subarachnoid haemorrhage (SAH). IL-1 receptor antagonist (IL-1Ra) limits brain injury in experimental stroke and reduces plasma inflammatory mediators associated with poor outcome in ischaemic stroke p...
Autores principales: | Singh, Navneet, Hopkins, Stephen J, Hulme, Sharon, Galea, James P, Hoadley, Margaret, Vail, Andy, Hutchinson, Peter J, Grainger, Samantha, Rothwell, Nancy J, King, Andrew T, Tyrrell, Pippa J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892121/ https://www.ncbi.nlm.nih.gov/pubmed/24383930 http://dx.doi.org/10.1186/1742-2094-11-1 |
Ejemplares similares
-
Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection
por: Hopkins, Stephen J, et al.
Publicado: (2012) -
The role of cortisol in immunosuppression in subarachnoid haemorrhage
por: Hoadley, Margaret E., et al.
Publicado: (2023) -
Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage
por: McMahon, Catherine J, et al.
Publicado: (2013) -
Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study
por: Galea, James, et al.
Publicado: (2011) -
Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology
por: Greenhalgh, Andrew D., et al.
Publicado: (2012)